BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22221053)

  • 1. Mapping the high throughput SEREX technology screening for novel tumor antigens.
    Zhou S; Yi T; Zhang B; Huang F; Huang H; Tang J; Zhao X
    Comb Chem High Throughput Screen; 2012 Mar; 15(3):202-15. PubMed ID: 22221053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of human tumor antigens by serological analysis of recombinant cDNA expression libraries (SEREX).
    Scanlan MJ
    Curr Protoc Immunol; 2005 Mar; Chapter 20():Unit 20.7. PubMed ID: 18432945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reverse proteomics for identification of tumor antigens.
    Lee SY; Jeoung D
    J Microbiol Biotechnol; 2007 Jun; 17(6):879-90. PubMed ID: 18050904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of tumor-associated autoantigens with SEREX.
    Türeci O; Usener D; Schneider S; Sahin U
    Methods Mol Med; 2005; 109():137-54. PubMed ID: 15585919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of humoral response to tumor antigens using recombinant expression-based serological mini-arrays (SMARTA).
    Lagarkova MA; Koroleva EP; Kuprash DV; Boitchenko VE; Kashkarova UA; Nedospasov SA; Shebzukhov YV
    Immunol Lett; 2003 Jan; 85(1):71-4. PubMed ID: 12505200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the B-cell repertoire against antigens expressed by human neoplasms.
    Preuss KD; Zwick C; Bormann C; Neumann F; Pfreundschuh M
    Immunol Rev; 2002 Oct; 188():43-50. PubMed ID: 12445280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential target antigens for immunotherapy identified by serological expression cloning (SEREX).
    Jäger D
    Methods Mol Biol; 2007; 360():319-26. PubMed ID: 17172736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display.
    Fosså A; Alsøe L; Crameri R; Funderud S; Gaudernack G; Smeland EB
    Cancer Immunol Immunother; 2004 May; 53(5):431-8. PubMed ID: 14747957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of prostate cancer antigens by automated high-throughput filter immunoscreening.
    Alsøe L; Stacy JE; Fosså A; Funderud S; Brekke OH; Gaudernack G
    J Immunol Methods; 2008 Jan; 330(1-2):12-23. PubMed ID: 18045611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening and sero-immunoscreening of ovarian epithelial cancer associative antigens].
    Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2007 Dec; 42(12):834-9. PubMed ID: 18476518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of tumour antigens by serological analysis of cDNA expression cloning.
    Li G; Miles A; Line A; Rees RC
    Cancer Immunol Immunother; 2004 Mar; 53(3):139-43. PubMed ID: 14722670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of tumor-associated antigens of lung cancer: SEREX combined with bioinformatics analysis.
    Wang Y; Wang P; Liu M; Zhang X; Si Q; Yang T; Ye H; Song C; Shi J; Wang K; Wang X; Zhang J; Dai L
    J Immunol Methods; 2021 May; 492():112991. PubMed ID: 33587914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploitation of the antibody repertoire of cancer patients for the identification of human tumor antigens.
    Türeci O; Sahin U; Zwick C; Neumann F; Pfreundschuh M
    Hybridoma; 1999 Feb; 18(1):23-8. PubMed ID: 10211784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen identification using SEREX.
    Sahin U; Türeci O
    Methods Mol Biol; 2013; 1061():59-77. PubMed ID: 23963930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives of SEREX-defined antigens in diagnosis and immunotherapy for gastric cancer.
    Wang Y; Gu Q; Liu B; Zhu Z
    Cancer Biol Ther; 2004 Sep; 3(9):806-11. PubMed ID: 15467426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SeroGRID: an improved method for the rapid selection of antigens with disease related immunogenicity.
    Krause P; Türeci O; Micke P; Buhl R; Huber C; Sahin U
    J Immunol Methods; 2003 Dec; 283(1-2):261-7. PubMed ID: 14659917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer.
    Lee SY; Williamson B; Caballero OL; Chen YT; Scanlan MJ; Ritter G; Jongeneel CV; Simpson AJ; Old LJ
    Cancer Immun; 2004 Nov; 4():13. PubMed ID: 15546177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploitation of the B cell repertoire for the identification of human tumor antigens.
    Pfreundschuh M
    Cancer Chemother Pharmacol; 2000; 46 Suppl():S3-7. PubMed ID: 10950139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigens recognized by autologous antibody in patients with renal-cell carcinoma.
    Scanlan MJ; Gordan JD; Williamson B; Stockert E; Bander NH; Jongeneel V; Gure AO; Jäger D; Jäger E; Knuth A; Chen YT; Old LJ
    Int J Cancer; 1999 Nov; 83(4):456-64. PubMed ID: 10508479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human esophageal carcinoma antigens screened by serologic analysis of recombinant cDNA expression libraries (SEREX)].
    Yu L; Hu H; Ran YL; Peng LP; Li JW; Yang ZH
    Ai Zheng; 2007 Jan; 26(1):100-5. PubMed ID: 17222377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.